Survival and Quality of Life of Patients Undergoing Lung Transplant

Clinics in Chest Medicine

Volumn 32, Issue 2, 2011, Pages 253-264

  Yusen, Roger D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung transplant; Outcomes assessment (health care); Quality of life; Survival analysis

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; CYCLOSPORIN; CYTOKINE RECEPTOR ANTAGONIST; EVEROLIMUS; INTERLEUKIN 2 RECEPTOR; PLACEBO; THYMOCYTE ANTIBODY;

AGE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DESCRIPTIVE RESEARCH; DONOR SELECTION; GRAFT FAILURE; GRAFT INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE; SURVIVAL TIME;

BRONCHIOLITIS OBLITERANS; HUMANS; LUNG TRANSPLANTATION; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WAITING LISTS;

EID: 79954606793     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.02.006     Document Type: Review

References (69)

1. Liou T.G., Adler F.R., Cox D.R., et al. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007, 357:2143-2152.
2. Sweet S.C., Aurora P., Benden C., et al. International pediatric lung transplant collaborative. Lung transplantation and survival in children with cystic fibrosis: solid statistics-flawed interpretation. Pediatr Transplant 2008, 12:129-136.
3. Yusen R.D. Lung transplantation outcomes: the importance and inadequacies of assessing survival. Am J Transplant 2009, 9:1493-1494. [editorial].
4. Yusen R.D. Technology and outcomes assessment in lung transplantation. Proc Am Thorac Soc 2009, 6:128-136.
5. Available at:, Accessed November 28, 2010. http://www.ustransplant.org/annual_reports/current/113_surv-new_dh.htm.
6. Yusen R.D., Shearon T.H., Qian Y., et al. Lung transplantation in the United States, 1999-2008. Am J Transplant 2010, 10(Part 2):1047-1068.
7. Christie J.D., Edwards L.B., Kucheryavaya A.Y., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant 2010, 29:1104-1118.
8. Hosenpud J.D., Bennett L.E., Keck B.M., et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998, 351:24-27.
9. De Meester J., Smits J.M., Persijn G.G., et al. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001, 20:518-524.
10. Charman S.C., Sharples L.D., McNeil K.D., et al. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002, 21:226-232.
11. Titman A., Rogers C.A., Bonser R.S., et al. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant 2009, 9:1640-1649.
12. Thabut G., Christie J.D., Kremers W.K., et al. Survival differences following lung transplantation among US transplant centers. JAMA 2010, 304:53-60.
13. Liou T.G., Adler F.R., Cahill B.C., et al. Correction: lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2008, 359:536.
14. Egan T.M., Murray S., Bustami R.T., et al. Development of the new lung allocation system in the United States. Am J Transplant 2006, 6:1212-1227.
15. Available at:, Accessed November 28, 2010. http://optn.transplant.hrsa.gov/resources/professionalResources.asp%3findex%3d88.
16. Available at:, Accessed November 28, 2010. http://optn.transplant.hrsa.gov/CommitteeReports/interim_main_ThoracicOrganTransplantationCommittee_5_1_2008_10_25.pdf.
17. Iacono A.T., Johnson B.A., Grgurich W.F., et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006, 354:141-150.
18. Available at: (Clinicaltrials.gov. Identifier NCT00755781). Accessed November 7, 2010. http://clinicaltrials.gov/ct2/show/NCT00755781%3fterm%3dnct00755781%26rank%3d1.
19. Snell G.I., Valentine V.G., Vitulo P., et al. RAD B159 Study Group. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial. Am J Transplant 2006, 6:169-177.
20. Available at:, (Clinicaltrials.gov. Identifier NCT00105183). Accessed November 21, 2010. http://clinicaltrials.gov/ct2/show/NCT00105183%3fterm%3dEZ-2053%26rank%3d1.
21. Hachem R.R., Edwards L.B., Yusen R.D., et al. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry. Clin Transplant 2008, 22:603-608.
22. Thabut G., Christie J.D., Ravaud P., et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008, 371:744-751.
23. Jain R., Hachem R.R., Morrell M.R., et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 2010, 29:531-537.
24. Johnson B.A., Iacono A.T., Zeevi A., et al. Statin use is associated with improved function and survival in lung allografts. Am J Respir Crit Care Med 2003, 167:1271-1278.
25. Yusen R.D., Brown K.L., Habrock T.E., et al. The impact of lung transplantation on quality of life in patients with COPD. J Heart Lung Transplant 2005, 24:S156-S157.
26. Ramsey S., Patrick D., Lewis S., et al. Improvement in quality of life after lung transplantation: a preliminary study. J Heart Lung Transplant 1995, 14:870-877.
27. Gartner S.H., Sevick M.A., Keenan R.J., et al. Cost-utility of lung transplantation: a pilot study. J Heart Lung Transplant 1997, 16:1129-1134.
28. Al M.J., Koopmanschap M.A., van Enckevort P.J., et al. Cost-effectiveness of lung transplantation in the Netherlands. A scenario analysis. Chest 1998, 113:124-130.
29. Anyanwu A.C., McGuire A., Rogers C.A., et al. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax 2001, 56:218-222.
30. Vasiliadis H.M., Collet J.P., Penrod J.R., et al. A cost-effectiveness and cost-utility study of lung transplantation. J Heart Lung Transplant 2005, 24:1275-1278.
31. Busschbach J.J., Horikx P.E., van den Bosch J.M., et al. Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest 1994, 105:911-917.
32. Squier H.C., Ries A.L., Kaplan R.M., et al. Quality of well-being predicts survival in lung transplantation candidates. Am J Respir Crit Care Med 1995, 152:2032-2036.
33. van Enckevort P.J., TenVergert E.M., Bonsel G.J., et al. Technology assessment of the Dutch Lung Transplantation Program. Int J Technol Assess Health Care 1998, 14:344-356.
34. Yusen R.D., Littenberg B., Brown K., et al. Validity of a computer-based patient preference instrument for assessing quality of life in COPD. Am J Respir Crit Care Med 1999, 159:A815.
35. Singer L.G., Gould M.K., Glidden D.V., et al. Effect of lung transplantation on quality-adjusted survival in emphysema. J Heart Lung Transplant 2002, 21:154.
36. Singer L.G., Theodore J. Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates. Med Decis Making 2003, 23:435-440.
37. Lobo F.S., Gross C.R., Matthees B.J. Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients. Qual Life Res 2004, 13:377-388.
38. Littlefield C., Abbey S., Fiducia D., et al. Quality of life following transplantation of the heart, liver, and lungs. Gen Hosp Psychiatry 1996, 18:36S-47S.
39. Limbos M.M., Chan C.K., Kesten S. Quality of life in female lung transplant candidates and recipients. Chest 1997, 112:1165-1174.
40. TenVergert E.M., Essink-Bot M.L., Geertsma A., et al. The effect of lung transplantation on health-related quality of life. Chest 1998, 113:358-364.
41. Cohen L., Littlefield C., Kelly P., et al. Predictors of quality of life and adjustment after lung transplantation. Chest 1998, 113:633-644.
42. MacNaughton K.L., Rodrigue J.R., Cicale M., et al. Health-related quality of life and symptom frequency before and after lung transplantation. Clin Transplant 1998, 12:320-323.
43. Lanuza D.M., McCabe M., Norton-Rosko M., et al. Symptom experiences of lung transplant recipients: comparisons across gender, pretransplantation diagnosis, and type of transplantation. Heart Lung 1999, 28:429-437.
44. Lanuza D.M., Lefaiver C., Mc Cabe M., et al. Prospective study of functional status and quality of life before and after lung transplantation. Chest 2000, 118:115-122.
45. Stavem K., Bjørtuft O., Lund M.B., et al. Health-related quality of life in lung transplant candidates and recipients. Respiration 2000, 67:159-165.
46. van Den Berg J.W., Geertsma A., van Der Bij W., et al. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med 2000, 161:1937-1941.
47. Matthees B.J., Anantachoti P., Kreitzer M.J., et al. Use of complementary therapies, adherence, and quality of life in lung transplant recipients. Heart Lung 2001, 30:258-268.
48. De Vito Dabbs A., Dew M.A., Stilley C.S., et al. Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart-lung transplantation. J Heart Lung Transplant 2003, 22:1268-1275.
49. Vermeulen K.M., Groen H., van der Bij W., et al. The effect of bronchiolitis obliterans syndrome on health related quality of life. Clin Transplant 2004, 18:377-383.
50. Gerbase M.W., Spiliopoulos A., Rochat T., et al. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest 2005, 128:1371-1378.
51. Kugler C., Fischer S., Gottlieb J., et al. Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant 2005, 24:2262-2268.
52. Rodrigue J.R., Baz M.A., Kanasky W.F., et al. Does lung transplantation improve health-related quality of life? The University of Florida experience. J Heart Lung Transplant 2005, 24:755-763.
53. Smeritschnig B., Jaksch P., Kocher A., et al. Quality of life after lung transplantation: a cross-sectional study. J Heart Lung Transplant 2005, 24:474-480.
54. Rodrigue J.R., Baz M.A. Are there sex differences in health-related quality of life after lung transplantation for chronic obstructive pulmonary disease?. J Heart Lung Transplant 2006, 25:120-125.
55. Girard F., Chouinard P., Boudreault D., et al. Prevalence and impact of pain on the quality of life of lung transplant recipients: a prospective observational study. Chest 2006, 130:1535-1540.
56. Vermeulen K.M., van der Bij W., Erasmus M.E., et al. Long-term health-related quality of life after lung transplantation: different predictors for different dimensions. J Heart Lung Transplant 2007, 26:188-193.
57. Gerbase M.W., Soccal P.M., Spiliopoulos A., et al. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome. J Heart Lung Transplant 2008, 27:898-904.
58. Vermeulen K.M., TenVergert E.M., Verschuuren E.A., et al. Pre-transplant quality of life does not predict survival after lung transplantation. J Heart Lung Transplant 2008, 27:623-627.
59. Limbos M.M., Joyce D.P., Chan C.K., et al. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000, 118:408-416.
60. Kugler C., Tegtbur U., Gottlieb J., et al. Health-related quality of life in long-term survivors after heart and lung transplantation: a prospective cohort study. Transplantation 2010, 90(4):451-457.
61. Yusen R.D. What outcomes should be measured in patients with COPD?. Chest 2001, 119:327-328.
62. von Neumann J., Morgenstern O. Theory of games and economic behavior 1953, Wiley, New York. 3rd edition.
63. Nease R.F., Kneeland T., O'Connor G.T., et al. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. JAMA 1995, 273:1185-1190.
64. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
65. Kaplan R., Atkins C., Timms R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis 1984, 37:85-95.
66. Sumner W., Nease R., Littenberg B. U-titer. A utility assessment tool. Med Decis Making 1991, 11:327.
67. Sumner W, Nease R, Littenberg B. U-titer: a utility assessment tool. Fifteenth Annual Symposium on Computer Applications in Medical Care. Washington, DC; 1991. p. 710-5.
68. Yusen R.D., Littenberg B. Integrating survival and quality of life data in clinical trials of lung disease. Chest 2005, 127:1094-1096.
69. Fishman A., Martinez F., Naunheim K., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003, 348:2059-2073.